Nabriva Therapeutics plc Bonus & Incentive Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
2020 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2020
Form of Contingent RSU Award Agreement under the 2020 Share Incentive Plan, as amended
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2022
2021 Inducement Share Incentive Plan, as amended
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Form of Share Option Agreement under the 2021 Inducement Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Form of Restricted Share Unit Agreement under the 2020 Share Incentive Plan, as amended (Automatic Sale)
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Form of Restricted Share Unit Agreement under the 2020 Share Incentive Plan, as amended (Share Withholding)
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Form of Share Option Agreement under the 2020 Share Incentive Plan, as amended
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
2021 Inducement Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Form of Share Option / Cash Settled Share Appreciation Right Agreement under the 2020 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2020
Form of Restricted Share Unit Agreement under the 2017 Share Incentive Plan (Share Withholding)
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2020
Form of Share Option Agreement under the 2017 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2018
Form of Restricted Share Unit Agreement under the 2017 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2018
2017 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2017